{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:11:17Z","timestamp":1763766677000,"version":"3.45.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,14]]},"abstract":"<jats:p>\n                    Early-stage adrenal cancer has a 5-year survival rate of 50% to 60% which drops to 10% to 20% following metastasis. We aim to identify the adrenal cancer mortality patterns across various demographics and geographies in the U.S. from 1999 to 2020 by using a national database. Death certificate-associated datasets were retrieved from the CDC WONDER database using the ICD-10 code C74 to identify adrenal cancer patients. age-adjusted mortality rates were calculated per million population along with annual percent changes in them for all the stratifications, including sex, race, and geography. Overall, 14,622 mortalities were attributed to adrenal cancer, with AAMR decreasing from 2.429 in 1999 to 2.068 in 2020 (APC\u20130.7804;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.05). Males (2.21) and non-Hispanic Whites (2.16) exhibited the highest rates. Older adults (6.09) reported the highest AAMR compared with younger populations. Further peak rates were observed among the residents of non-metropolitan areas (2.32) and the Midwest region (2.23). Overall, the mortality rates declined, but significant demographic and regional disparities exist, emphasizing the need for targeted interventions chiefly for older individuals, men, and those in non-metropolitan areas.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045882","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:01:26Z","timestamp":1763154086000},"page":"e45882","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Trends in adrenal cancer mortality in the US: Regional, demographic and geographic disparities from 1999 to 2020"],"prefix":"10.1097","volume":"104","author":[{"given":"Hassan","family":"Ijaz","sequence":"first","affiliation":[{"name":"Department of Medicine, King Edward Medical University, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Shaheer Bin","family":"Faheem","sequence":"additional","affiliation":[{"name":"Department of Medicine, Karachi Institute of Medical Sciences, KIMS, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamikha","family":"Cheema","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Edward Medical University, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pakeeza","family":"Saif","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Edward Medical University, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azka","family":"Ijaz","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Edward Medical University, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafiq Ur","family":"Rahman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Saidu Group of Teaching Hospital Swat, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romaisa","family":"Kunwar","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Edward Medical University, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Tawassul","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Karachi Medical and Dental College, KMDC, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umaima","family":"Cheema","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Edward Medical University, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Manzoor","sequence":"additional","affiliation":[{"name":"Department of Medicine, Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2618-1211","authenticated-orcid":false,"given":"Muhammad Idrees","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Adam University School of Medicine, Bishkek, Chuy Region, Kyrgyzstan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251121","doi-asserted-by":"crossref","first-page":"20406223211033103","DOI":"10.1177\/20406223211033103","article-title":"Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment.","volume":"12","author":"Shariq","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"R2-20251121","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma.","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"R3-20251121","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/cncr.23886","article-title":"Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors.","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer"},{"key":"R4-20251121","first-page":"100759","article-title":"Adrenocortical carcinoma: diagnosis, prognostic classification and treatment of localized and advanced disease.","volume":"37","author":"Lib\u00e9","year":"2023","journal-title":"Cancer Treat Res Commun"},{"key":"R5-20251121","article-title":"SEER*Explorer: An interactive website for SEER cancer statistics."},{"key":"R6-20251121","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2217\/ije-2015-0003","article-title":"Adrenocortical carcinoma: modern management and evolving treatment strategies.","volume":"3","author":"McDuffie","year":"2016","journal-title":"Int J Endocr Oncol"},{"key":"R7-20251121","doi-asserted-by":"crossref","first-page":"e18763","DOI":"10.1200\/JCO.2024.42.4_suppl.4","article-title":"A meta-analysis of overall survival and response in metastatic adrenocortical carcinoma: a review of 23 prospective trials of 880 patients.","volume":"42","author":"Hall","year":"2024","journal-title":"J Clin Oncol"},{"key":"R8-20251121","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.soc.2012.03.012","article-title":"Racial differences and disparities in cancer care and outcomes: where\u2019s the rub?","volume":"21","author":"Esnaola","year":"2012","journal-title":"Surg Oncol Clin N Am"},{"key":"R9-20251121","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1210\/jc.2016-2894","article-title":"Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma.","volume":"102","author":"Berruti","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20251121","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ejca.2009.12.007","article-title":"The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation.","volume":"46","author":"Lughezzani","year":"2010","journal-title":"Eur J Cancer"},{"key":"R11-20251121","article-title":"Multiple Cause of Death 1999\u20132019."},{"key":"R12-20251121","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2105\/AJPH.83.9.1289","article-title":"CDC WONDER: a comprehensive on-line public health information system of the Centers for Disease Control and Prevention.","volume":"83","author":"Friede","year":"1993","journal-title":"Am J Public Health"},{"year":"2024","key":"R13-20251121"},{"key":"R14-20251121","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R15-20251121","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study.","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R16-20251121","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1158\/1055-9965.EPI-08-1118","article-title":"Sex disparities in cancer incidence by period and age.","volume":"18","author":"Cook","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R17-20251121","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fgene.2012.00268","article-title":"Gender differences in cancer susceptibility: an inadequately addressed issue.","volume":"3","author":"Dorak","year":"2012","journal-title":"Front Genet"},{"key":"R18-20251121","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00345-012-1011-1","article-title":"Adrenal tumours are more predominant in females regardless of their histological subtype: a review.","volume":"31","author":"Audenet","year":"2013","journal-title":"World J Urol"},{"key":"R19-20251121","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1097-0215(19960208)65:4<432::AID-IJC6>3.0.CO;2-Y","article-title":"Risk factors for adrenal cancer: an exploratory study.","volume":"65","author":"Hsing","year":"1996","journal-title":"Int J Cancer"},{"key":"R20-20251121","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1093\/ejendo\/lvaf088","article-title":"Sexual dimorphism in benign adrenocortical tumours.","volume":"192","author":"Suntornlohanakul","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"R21-20251121","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1158\/1055-9965.EPI-17-0092","article-title":"Making the case for investment in rural cancer control: an analysis of rural cancer incidence, mortality, and funding trends.","volume":"26","author":"Blake","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R22-20251121","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3390\/microorganisms12101978","article-title":"Antibiotic resistance in the elderly: mechanisms, risk factors, and solutions.","volume":"12","author":"Theodorakis","year":"2024","journal-title":"Microorganisms"},{"key":"R23-20251121","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0889-8529(05)70113-4","article-title":"Adrenal cancer.","volume":"29","author":"Stratakis","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R24-20251121","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/1097-0142(197907)44:1<239::AID-CNCR2820440139>3.0.CO;2-R","article-title":"Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases.","volume":"44","author":"King","year":"1979","journal-title":"Cancer"},{"key":"R26-20251121","doi-asserted-by":"crossref","first-page":"636","DOI":"10.14740\/jocmr3503w","article-title":"The characteristics and trends in adrenocortical carcinoma: a United States population based study.","volume":"10","author":"Sharma","year":"2018","journal-title":"J Clin Med Res"},{"key":"R27-20251121","doi-asserted-by":"crossref","first-page":"bvaa110","DOI":"10.1210\/jendso\/bvaa110","article-title":"Racial disparities of adrenalectomy.","volume":"4","author":"Holoubek","year":"2020","journal-title":"J Endocr Soc"},{"key":"R28-20251121","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jss.2022.05.011","article-title":"Treatment differences for adrenocortical carcinoma by race and insurance status.","volume":"280","author":"Holoubek","year":"2022","journal-title":"J Surg Res"},{"key":"R29-20251121","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev-soc-081715-074226","article-title":"Social foundations of health care inequality and treatment bias.","volume":"42","author":"Spencer","year":"2016","journal-title":"Ann Rev Sociol"},{"key":"R30-20251121","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.21873\/anticanres.16065","article-title":"Hispanic vs. Caucasian race\/ethnicity in adrenocortical carcinoma patients.","volume":"42","author":"Panunzio","year":"2022","journal-title":"Anticancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:01:50Z","timestamp":1763766110000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":29,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045882","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"2025-07-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}